HCA Healthcare announced a robust fourth quarter for 2025, with revenues increasing by 6.7% to $19.513 billion and net income attributable to HCA Healthcare, Inc. surging by 30.6% to $1.878 billion. Diluted earnings per share rose significantly by 44.6% to $8.14, while Adjusted EBITDA increased by 10.8% to $4.114 billion, reflecting strong performance consistent with previous quarters.

HCA Healthcare delivered a solid Q3 2025 with increases in revenue, EPS, and net income. The company benefited from operational efficiency and increased admissions, and it raised its full-year guidance as a result.

HCA Healthcare delivered solid Q2 2025 results with revenue and net income growth driven by improved margins and higher admissions, while also raising full-year guidance.

HCA Healthcare delivered strong results in Q1 2025 with growth in revenue, net income, and admissions, despite pressures on outpatient surgeries and cash flow from operations.

HCA Healthcare reported revenues of $18.285 billion and net income of $1.438 billion for the fourth quarter of 2024. The company's performance was driven by increased admissions and equivalent admissions, reflecting continued growth and operational efficiency.

HCA Healthcare reported a strong third quarter with revenue of $17.487 billion and net income of $1.270 billion, or $4.88 per diluted share. Results were impacted by Hurricane Helene, which unfavorably impacted EPS by an estimated $0.15. The company reaffirmed its 2024 guidance, but expects results to be in the lower half of the provided ranges due to hurricane impacts.

HCA Healthcare reported strong second-quarter results with revenues of $17.492 billion and net income of $1.461 billion, or $5.53 per diluted share. The company's performance reflected strong demand for its services and effective execution of its strategic plan. HCA Healthcare also raised its 2024 guidance.

HCA Healthcare reported strong first-quarter results, driven by broad-based volume growth. Revenues increased to $17.339 billion, and net income attributable to HCA Healthcare, Inc. rose to $1.591 billion, or $5.93 per diluted share.

HCA Healthcare reported revenues of $17.303 billion and net income of $1.607 billion for the fourth quarter of 2023. The company experienced strong demand for services and improved cost trends, contributing to the positive financial results.

HCA Healthcare reported a revenue increase to $16.213 billion, up from $14.971 billion in Q3 2022. Net income attributable to HCA Healthcare, Inc. was $1.079 billion, or $3.91 per diluted share, which is slightly lower than the $1.134 billion reported in Q3 2022. The company revised its 2023 guidance for revenue, net income, and adjusted EBITDA.

HCA Healthcare reported solid second-quarter results, driven by strong demand and effective execution, with revenues reaching $15.861 billion and net income attributable to HCA Healthcare, Inc. totaling $1.193 billion, or $4.29 per diluted share.

HCA Healthcare reported a strong first quarter in 2023, with revenues increasing to $15.591 billion and net income attributable to HCA Healthcare, Inc. totaling $1.363 billion, or $4.85 per diluted share. The company saw increases in same facility admissions and equivalent admissions, reflecting strong demand for its services. HCA also repurchased 3.340 million shares of its common stock at a cost of $846 million and revised its 2023 guidance upwards.

HCA Healthcare reported a strong fourth quarter in 2022, with revenues totaling $15.497 billion and net income attributable to HCA Healthcare, Inc. reaching $2.081 billion, or $7.28 per diluted share. The company's performance benefited from increased same facility admissions and equivalent admissions.

HCA Healthcare reported a decrease in revenues and net income for the third quarter of 2022 compared to the same period in 2021. Revenues totaled $14.971 billion, and net income attributable to HCA Healthcare was $1.134 billion, or $3.91 per diluted share. The results were impacted by a difficult comparison to the prior year due to the COVID-19 Delta variant and Hurricane Ian.

HCA Healthcare reported a revenue increase for Q2 2022, but experienced a decrease in net income and diluted earnings per share compared to Q2 2021. The results reflect challenges related to the labor market and inflationary pressures.

HCA Healthcare reported a revenue increase for Q1 2022, but net income decreased. The company revised its 2022 guidance due to inflationary pressures on labor costs.

HCA Healthcare reported a revenue increase to $15.064 billion for Q4 2021, compared to $14.293 billion in Q4 2020. Net income attributable to HCA Healthcare, Inc. increased to $1.814 billion, or $5.75 per diluted share, compared to $1.426 billion, or $4.13 per diluted share, in the same quarter of the previous year. The company also provided 2022 guidance, increased capital spending, authorized an additional share repurchase program, and increased the quarterly dividend.

HCA Healthcare reported a strong third quarter in 2021 with revenues of $15.276 billion and net income of $2.269 billion, driven by increased patient volumes and gains on sales of facilities, despite the challenges posed by the Delta variant.

HCA Healthcare reported strong second quarter 2021 results, with revenues increasing to $14.435 billion and net income attributable to HCA Healthcare, Inc. totaling $1.450 billion, or $4.36 per diluted share. The company raised its 2021 guidance for revenues, adjusted EBITDA, and EPS.

HCA Healthcare reported strong first-quarter results with revenues of $13.977 billion and net income of $1.423 billion, or $4.14 per diluted share. The company also revised its 2021 full-year guidance, reflecting confidence in its operating performance.

HCA Healthcare reported strong financial results for Q4 2020, driven by highly acute inpatient volumes and solid cost management. Revenues increased to $14.293 billion, and net income attributable to HCA Healthcare, Inc. totaled $1.426 billion, or $4.13 per diluted share.

HCA Healthcare reported a revenue increase to $13.311 billion compared to $12.694 billion in the third quarter of 2019. Net income attributable to HCA Healthcare, Inc. increased to $668 million, or $1.95 per diluted share, compared to $612 million, or $1.76 per diluted share, in the third quarter of 2019. The results include a reversal of government stimulus income from CARES Act funds. Cash flows from operating activities totaled $2.717 billion.

HCA Healthcare reported a decrease in revenues but an increase in net income for the second quarter of 2020. Revenues totaled $11.068 billion, while net income attributable to HCA Healthcare, Inc. totaled $1.079 billion, or $3.16 per diluted share. The company recognized $822 million in government stimulus income during the quarter.

HCA Healthcare's Q1 2020 results were impacted by the COVID-19 pandemic, leading to a decrease in net income despite a slight increase in revenues. The company has withdrawn its 2020 guidance due to uncertainty related to the pandemic.

HCA Healthcare reported a revenue of $13.523 billion and net income of $1.071 billion for Q4 2019. Adjusted EBITDA totaled $2.738 billion. Same facility admissions and equivalent admissions increased by 4.7% and 5.0%, respectively.